Page 32 - JCTR-10-5
P. 32

294                       Omrani et al.| Journal of Clinical and Translational Research 2024; 10(5): 291-295
        addition, Williams et al. revealed that there is no relationship   for Children’s Health, Shahid Beheshti University of Medical
        between gender and the recovery rate of the immune system   Sciences, Tehran, Iran for their kind cooperation.
        after chemotherapy cessation [18]. They also reported that the
        WBC  level  did  not  change  significantly  with  increased  time   Funding
        after treatment cessation.                               This research did not receive any specific grant from funding
          The  present  study  displayed  increased  levels  of  WBC,   agencies in public, commercial, or not-for-profit sectors.
        lymphocytes,  and neutrophils 6  months after  treatment
        cessation. Several studies confirmed this finding [8,18]. Perkins   Conflicts of Interest
        et al. investigated the immune system status immediately and   The authors declare that they have no competing interests.
        6 months after treatment cessation in 20 patients with ALL and
        acute  myeloid  leukemia;  it  was reported  that  the  number  of   Ethics Approval and Consent to Participate
        WBCs decreased at both times, but this decrease is compensated
        to some extent after 6 months following treatment cessation [8].   This  study  was  approved  by  the  Ethics  Committee  of
        In a study by Kosmidis et al., it was also reported that children   Pediatric Congenital Hematologic Disorders Research Center,
        experienced significant neutropenia during the first few months   Shahid Beheshti University of Medical Sciences, Tehran, Iran
        of treatment,  but  this  is less  common  during  maintenance   (IRSBMU.MSP.REC.1399.473). A questionnaire was designed
        chemotherapy [19]. However, lymphopenia with low levels of   for each child, and written informed consent was acquired from
        B and T cells is common and has been reported to persist for up   their parents during the course of sample collection.
        to 6 months after treatment [14,19].                   Consent for Publication
          In this study, the average antibody level against diphtheria and
        tetanus increased 6 months after treatment, whereas the average   We explained the aims of the present study to children and
        antibody  level  against hepatitis B decreased. Although these   their parents.  A questionnaire was  planned for each of the
        changes  were  not  significant,  the  immune  system  restoration   included children and written informed consent was obtained
        resulted  in  increases  in  WBCs  and  IgG,  IgM,  IgE,  and  IgA   from all children and their parents during the study.
        in this study and previous studies [18,20], and an increase in   Availability of Data
        antibody levels against diphtheria and tetanus was also expected.
        The decrease in antibodies  against hepatitis  requires further   All data generated or analyzed during this study are included
        investigation; it may also return to the average level in a more   in this published article.
        extended  period, as studies have reported that some changes
        in immune system reconstruction occur in the long term [19].   References
        Collectively, we revealed improvement of the humoral immune   [1]   Namayandeh SM, Khazaei Z, Najafi ML, Goodarzi E,
        system to some extent after 6  months of chemotherapy, but   Moslem A. Global Leukemia in Children 0-14 Statistics
        similar to Perkins et al., some degree of defects in the immune   2018, Incidence and Mortality and Human Development
        system were also reported [8].                              Index (HDI): GLOBOCAN Sources and Methods. Asian
          One of the limitations  of this research is that  the sample   Pac J Cancer Prev 2020;21:1487.
        patient population was small, and a study with a more significant      doi: 10.31557/APJCP.2020.21.5.1487
        population is warranted. In addition, this study did not separate
        the  different  types  of leukemia,  and  it  is  recommended  that   [2]   Hunger  SP,  Mullighan  CG.  Acute  Lymphoblastic
        future studies distinguish between these types for a more   Leukemia   in   Children.   New   Engl   J   Med
        detailed investigation.                                     2015;373(16):1541-52.
                                                                    doi: 10.1056/NEJMra1400972
        5. Conclusion                                          [3]   Steinherz PG, Brown AE, Gross PA, Braun D, Ghavimi F,

          The  findings  of  this  study  indicate  that  the  status  of  the   Wollner  N,  et al.  Influenza  Immunization  of  Children
        humoral immune system exhibits slight improvement 6 months   with Neoplastic Diseases. Cancer 1980;45:750-6.
        after the end of chemotherapy compared to the initial assessment.      doi:   10.1002/1097-0142(19800215)45:4<750::aid-
        In addition, there is no difference between age and the condition   cncr2820450423>3.0.co;2-z
        of the humoral immune system in the patients 6 months after   [4]   Tavakol M, Delavari S, Salami F, Ansari S, Rasouli SE,
        chemotherapy  treatment.  We indicated  that  survivors of   Chavoshzadeh  Z,  et al. Diversity of Malignancies
        childhood cancer have ongoing humoral immunological defects   in  Patients  with  Different  Types  of  Inborn  Errors  of
        and may remain at risk for infectious complications  after   Immunity. Allergy Asthma Clin Immunol 2022;18:106.
        completion of therapy.                                      doi: 10.1186/s13223-022-00747-2
        Acknowledgments                                        [5]   Griggio  V,  Perutelli  F,  Salvetti  C,  Boccellato  E,
                                                                    Boccadoro  M,  Vitale  C,  et al. Immune Dysfunctions
          The  authors  would  like  to  thank  the  Pediatric  Congenital   and  Immune-based  Therapeutic  Interventions  in
        Hematologic  Disorders  Research  Center,  Research  Institute   Chronic  Lymphocytic  Leukemia.  Front  Immunol

                                               DOI: http://doi.org/10.36922/jctr.24.00050
   27   28   29   30   31   32   33   34   35   36   37